Phase
Condition
Carcinoma
Urothelial Carcinoma
Treatment
Avelumab
Clinical Study ID
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Participants diagnosed with locally advanced/metastatic urothelial carcinoma (la/mUC) before receiving avelumab first line maintenance therapy
Participants with la/m UC (irrespective of tumor histology) whose disease has notprogressed (ongoing stable disease, partial response, or complete response)following completion of first line PBCT and who has been treated with avelumab
Participants who has been started avelumab first line maintenance therapy for la/mUC from 24 Feb 2021 (date of approval for UC) to 6 months before the date ofapproval of implementation of this study at each site
Participants aged >= 18 years old at index date
Other protocol defined inclusion criteria could apply
Exclusion
Exclusion Criteria:
- Participant participated in a clinical trial in la/m UC during the study periods.
Study Design
Connect with a study center
Hirosaki University Hospital
Hirosaki, Aomori 036-8563
JapanSite Not Available
Ehime University Hospital
Toon, Ehime 791-0295
JapanSite Not Available
Kurume University Hospital
Kurume, Fukuoka 830-0011
JapanSite Not Available
Hokkaido University Hospital
Sapporo, Hokkaido 060-8648
JapanSite Not Available
Sapporo Medical University Hospital
Sapporo, Hokkaido 060-8648
JapanSite Not Available
Kobe University Hospital
Kobe, Hyogo 650-0017
JapanSite Not Available
Iwate Medical University Hospital
Shiwa-gun, Iwate 028-3695
JapanSite Not Available
Kagawa University Hospital
Kita-gun, Kagawa 761-0793
JapanSite Not Available
St. Marianna University Hospital
Kawasaki, Kanagawa 216-8511
JapanSite Not Available
Kitasato University Hospital
Sagamihara, Kanagawa 252-0374
JapanSite Not Available
Nara Medical University Hospital
Kashihara, Nara 634-8522
JapanSite Not Available
Kindai University Hospital
Osakasayama, Osaka 589-8511
JapanSite Not Available
Saitama Medical University International Medical Center
Hidaka, Saitama 350-1298
JapanSite Not Available
Juntendo University Hospital
Bunkyo-ku, Tokya 113-0033
JapanSite Not Available
Nippon Medical School Hospital
Bunkyo-ku, Tokyo 113-8603
JapanSite Not Available
National Cancer Center Hospital
Chuo-ku, Tokyo 104-0045
JapanSite Not Available
Teikyo University Hospital
Itabashi-ku, Tokyo 173-8606
JapanSite Not Available
Akita University Hospital
Akita, 010-0041
JapanSite Not Available
Kyushu Cancer Center
Fukuoka, 811-1347
JapanSite Not Available
Kumamoto University Hospital
Kumamoto, 860-8556
JapanSite Not Available
Kyoto University Hospital
Kyoto, 606-8507
JapanSite Not Available
University Hospital Kyoto Prefectural University of Medicine
Kyoto, 602-8566
JapanSite Not Available
Osaka International Cancer Institute
Osaka, 540-0008
JapanSite Not Available
Tokushima University Hospital
Tokushima, 770-0042
JapanSite Not Available
Toyama University Hospital
Toyama, 930-0194
JapanSite Not Available
Yamagata University Hospital
Yamagata, 9902331
JapanSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.